InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Shiferman Gregory L.. Director active across 1 company, notably Sage Therapeutics, Inc.. Aggregated, 7 disclosures have been recorded. History available since 1 November 2024. The latest transaction was filed on 10 April 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
7 of 7 declarations